Neurosurgeon Advisory Board Member

This role is designed for nationally respected neurosurgeons who bring experience in clinical governance, multidisciplinary program development, quality improvement, health system leadership, or scalable specialty model expansion.While the clinical focus centers on neurocognitive disease and brain health platforms, the perspective of a neurosurgeon is invaluable in protocol standardization, enterprise oversight, safety assurance, and structured systems based care delivery.As a Neurosurgeon Advisory Board Member, you will provide high level strategic guidance to ensure expanding precision medicine platforms maintain clinical integrity, operational scalability, and measurable patient outcomes.You will collaborate with executive leadership, clinical operations teams, and data science partners to strengthen governance infrastructure, quality frameworks, and responsible growth strategies.About Alzheimer's Treatment Centers of America (ATCA)Alzheimer's Treatment Centers of America (ATCA) leverages Artificial Intelligence (AI) and Personalized Precision Medicine to transform the treatment of Alzheimer's disease, dementia, and cognitive impairment, including brain fog associated with Long COVID.This is about delivering structured, data driven treatment to patients today. ATCA goes beyond traditional diagnosis to identify underlying contributors to neurodegeneration and cognitive dysfunction, implementing individualized treatment protocols designed to slow progression and improve functional outcomes.Our multidisciplinary leadership team includes experienced healthcare executives, neuroscientists, AI engineers, and clinical specialists working together to deploy a scalable, neurologist supported clinic model nationwide. As we expand, we are building a governance framework supported by senior physician leaders who understand clinical rigor, operational scalability, and health system integration.Why Now?Growing Community Need: Our Palm Beach Gardens/Jupiter clinic is fully operational and actively treating patients in a high visibility medical corridor adjacent to Cleveland Clinic. Originally launched in a former urgent care space to enable rapid deployment, the clinic reached capacity quickly, with appointments booked months in advance reflecting significant unmet demand for proactive cognitive care.Three additional clinics are in development, with broader national expansion underway. ATCA is building a repeatable, specialist supported specialty model that expands access to structured cognitive evaluation and longitudinal management while maintaining clinical rigor and operational scalability.Seamless System Integration: ATCA's care model integrates within the existing healthcare ecosystem. Treatments are reimbursed by Medicare, Medicare Advantage, and most major commercial insurers, reducing barriers to access and accelerating patient adoption.Focused on Outcomes: In a study utilizing ATCA's AI driven protocol, 75% of patients with mild cognitive impairment demonstrated no further cognitive decline. This represents a data driven, proactive approach that complements traditional management pathways and emphasizes measurable outcomes.Advanced Therapeutic Options: Eligible patients may have access to TB006, an FDA approved therapy available for compassionate use, providing a potential treatment pathway for certain dementias, including Alzheimer's disease.Physician Supported: ATCA's protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. As we expand nationally, we are strengthening this advisory infrastructure with senior surgical leaders who bring expertise in clinical governance, quality assurance, scalability, and system based care delivery.Key AchievementsProprietary AI Precision Engine: ATCA has built and deployed a defensible AI driven precision medicine platform that optimizes Alzheimer's treatment at the individual patient level, creating strong clinical differentiation and long-term data network effects.High Margin, Replicable Clinic Model: Engineered a scalable specialty clinic platform targeting 44% EBITDA margins, driven by optimized staffing ratios, high-acuity service mix, and strong reimbursement dynamics designed for rapid multi-market expansion.Massive, Underserved Market Opportunity: Positioned to capture share in a $355B U.S. Alzheimer's market and a $1.5T global opportunity, addressing one of the largest and fastest growing unmet needs in healthcare.Embedded Revenue-Generating Research Infrastructure: Integrated micro research capabilities within each clinic to generate real world evidence, pharmaceutical partnerships, clinical trial participation, and recurring high margin ancillary revenue streams.Responsibilities IncludeClinical Governance & Oversight: Provide executive level advisory input to safeguard protocol standardization, patient safety measures, and quality assurance systems.Operational Scalability: Advise on replicable clinical workflows and multidisciplinary coordination strategies that support national expansion without compromising rigor.Quality & Outcomes Strategy: Contribute to the development of longitudinal tracking systems, measurable performance benchmarks, and evidence based reporting structures.Interdisciplinary Collaboration: Partner with neurologists, advanced practice providers, data scientists, and executive leaders to ensure coordinated, patient centered care delivery.Innovation & Technology Review: Offer perspective on responsible integration of AI driven tools, advanced analytics, and emerging therapeutic models.Health System & Payer Alignment: Guide positioning within hospital networks, referral ecosystems, and reimbursement frameworks.Strategic Growth Advisory: Provide insight on risk mitigation, governance maturity, and maintaining clinical credibility during accelerated scale.Why Join Us?Strategic Influence: Shape the governance architecture of rapidly expanding AI enabled brain health platforms.Board Level Engagement: Contribute at the advisory level without day to day operational responsibility.Impact at Scale: Help ensure innovative cognitive care models expand responsibly while preserving the highest standards of neurosurgical oversight.Enterprise Level Perspective: Apply surgical leadership experience to one of the most urgent and fastest growing areas in healthcare.Clinical Integrity During Innovation: Safeguard rigor, accountability, and patient safety as precision medicine platforms scale nationally.Compensation / PerksEquity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA's mission.Investment Access: Select advisory board members may be offered access to ATCA's current financing round. Participation is optional and independent of the advisory role.Equal Opportunity CommitmentATCA is committed to fostering an inclusive environment. We believe diversity drives innovation and welcome individuals from all backgrounds to join us in transforming Alzheimer's treatment.